Contents

Search


rezafungin (Rezzayo)

Indications: - candidemia - invasive candidiasis Dosage: - 400 mg loading dose IV followed by 200 mg IV weekly for up to 4 weeks Adverse effects: - tremor

General

antifungal agent

Database Correlations

PUBCHEM correlations

References

  1. Hein I FDA Panel Backs Weekly Rezafungin for Candidemia, Invasive Candidiasis. Efficacy, safety data sufficient to justify "limited use" indication, say panelists. MedPage Today January 25, 2023 https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/102799